Menu
Search
|

Menu

Close
X

Eisai Co Ltd 4523.T (Tokyo Stock Exchange)

7,565.00 JPY
-1,500.00 (-16.55%)
As of Mar 22
chart
Previous Close 9,065.00
Open 7,565.00
Volume 134,100
3m Avg Volume 801,880
Today’s High 7,565.00
Today’s Low 7,565.00
52 Week High 11,490.00
52 Week Low 6,554.00
Shares Outstanding (mil) 296.57
Market Capitalization (mil) 2,243,529.00
Forward P/E 34.03
Dividend (Yield %) 80.00 ( 1.98 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.55 Mean rating from 11 analysts

KEY STATS

Revenue (mm, JPY)
FY19
467,253
FY18
600,054
FY17
539,097
FY16
547,923
EPS (JPY)
FY19
139.461
FY18
180.967
FY17
137.415
FY16
191.769
*Note: Units in Millions of Yen
**Note: Units in Yen

KEY RATIOS

Price to Earnings (TTM)
vs sector
34.03
58.10
Price to Sales (TTM)
vs sector
3.58
8.84
Price to Book (MRQ)
vs sector
3.61
4.60
Price to Cash Flow (TTM)
vs sector
23.77
40.07
Total Debt to Equity (MRQ)
vs sector
21.66
17.66
LT Debt to Equity (MRQ)
vs sector
14.99
13.97
Return on Investment (TTM)
vs sector
8.90
12.12
Return on Equity (TTM)
vs sector
10.71
13.24

EXECUTIVE LEADERSHIP

Yasuhiko Kato
Chairman of the Board of Directors, Independent Director, Since 2018
Salary: --
Bonus: --
Haruo Naito
Chief Executive Officer, Representative Executive Officer, Director, Since 2014
Salary: --
Bonus: --
Ryohei Yanagi
Managing Executive Officer, Chief Financial Officer, Chief IR Officer, Since 2015
Salary: --
Bonus: --
Hideki Hayashi
Representative Executive Officer, Chief Information Officer, Since 2016
Salary: --
Bonus: --
Junichi Asatani
Executive Officer, Chief Compliance Officer, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Eisai Main Bldg., 4-6-10, Koishi
BUNKYO-KU   TKY   112-8088

Phone: +813.38173700

Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.

SPONSORED STORIES